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To determine whether coronary thrombi can be detected
scintigraphically after acute myocardial infarction, 24
patients were studied with a new method employing in-
dium-Ill-labeled platelets and technetium-99m-labeled
red blood cells. Nine patients with suspected infarction
were evaluated initially within 9 hours of the onset of
symptoms and again 18 to 24 hours after onset. Eight
patients with neurologic symptoms but without overt
cardiac disease and seven patients with angina but with-
out infarction served as unmatched control subjects. Foci
of net indium accumulation were detected after image
processing that incorporated subtraction of blood pool
activity. Carotid and pulmonary artery reference re-
gions, in which blood pool activity is high and active
platelet deposition unlikely, were used to correct digi-
tized cardiac scintigrams for indium-Ill platelet activity
in the blood pool.
In patients with infarction, distinct foci of net indium
accumulation were present in regions corresponding to
The high frequency of coronary thrombi detectable by an-
giography early after onset of myocardial infarction and the
feasibility of thrombolytic therapy have intensified the in-
terest in noninvasive detection of coronary thrombi and char-
acterization of the pathogenetic role of platelets in their
initiation and perpetuation (1-6). Objective evaluation of
interventions designed either to inhibit platelet aggregation
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the coronary artery supplying ischemic zones. This oc-
curred in seven of eight patients at the time of the earliest
evaluation (5.6 ± 3.3 hours [mean ± SD] after the
onset of symptoms) and in eight of nine patients at the
time of subsequent imaging (23.6 ± 1.9 hours after on-
set). Only 1 of the 15 control patients exhibited a cardiac
focus of net indium accumulation. The percent of indium
excess (100[total indium-11I activity-blood pool indium-
111 activity]/blood pool indium-Ill activity) within the
cardiac region measured (± SD) 16.8 ± 11.6% in all
patients with myocardial infarction (19.1 ± 11.2% in
those with visually identified foci) compared with 0.4 ±
4.3% in control patients (p < 0.001).
This method permits early detection and sequential
assessment of coronary artery thrombi. It should permit
improved characterization of the role of platelets in the
pathogenesis of acute manifestations of coronary vas-
cular disease and improved evaluation of interventions
designed to prevent or lyse coronary thrombi.
or to induce thrombolysis would be facilitated by a method
for serial noninvasive assessment of thrombi. Currently
available in vitro assays provide estimates of platelet ag-
gregation and degranulation, but do not provide information
concerning the site or sites of platelet accumulation or permit
serial estimation of the extent of incorporation of platelets
into thrombi.
Platelets labeled with indium-Ill (7,8) have been used
for scintigraphic detection of arterial, venous and coronary
thrombi (8-10), atherosclerotic lesions (9,11-13), trans-
plant rejection (14), myocardial inflammation (15), endo-
carditis (16) and ventricular thrombi (17). Sensitivity for
the detection of cardiac lesions has been limited, particularly
in scintigrams obtained relatively early after injection of
labeled platelets, by the large amount of radioactivity as-
sociated with circulating platelets which tends to mask ac-
tivity of platelets incorporated into thrombi. Accordingly,
we recently developed a method to improve indium-Ill
platelet scintigraphy by employing vascular pool subtraction
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(12,18). The quantitative accuracy of this technique has
been validated in experimental animals (19). It has been
shown to provide considerable specificity and sensitivity for
detection of coronary thrombi as small as 12 mg in dogs
(20). For this procedure, autologous red blood cells are
labeled with technetium-99m and employed as a marker of
blood pool activity. Digitized cardiac platelet scintigrams
are corrected on a pixel by pixel basis for the contribution
of circulating indium platelet activity by determining tech-
netium-99m and indium-Ill activity in the blood pool from
selected reference regions. This permits calculation of ac-
tivity associated with circulating platelets and differentiation
of this activity from activity associated with platelets in-
corporated into thrombi. In experimental animals, we re-
cently showed (20) that accumulation of indium-Ill plate-
lets in thrombi can be detected readily by the subtraction
technique.
The present study was designed to determine whether
labeled platelets can be used to detect coronary thrombi in
patients with evolving acute myocardial infarction. It was
not performed to define specificity and sensitivity in the
patients with transmural infarction selected for this study,
but rather to determine the feasibility of the approach for
application to patients. Nevertheless, the high frequency
with which coronary thrombi were detected in this study is
consistent with the incidence of thrombosis suggested by
the angiographic observations of others (2). Moreover, our
results indicate an apparent low false positive rate and a
high sensitivity of the noninvasive method developed.
Methods
Patients. Dual isotope platelet scintigraphy was per-
formed in 24 patients, each of whom gave written informed
consent before participation in this study. Nine patients had
sustained chest pain typical of ischemia and of greater than
30 minutes duration and exhibited new Q waves of at least
30 ms duration and 0.2 mY amplitude or new ST segment
elevation of at least 0. 1 mY in two of the three diaphagmatic
leads, two of the six precordial leads or leads I and aYL.
Infarction subsequently was confirmed in each of these nine
patients by analysis of plasma creatine kinase-MB activity.
None of the patients was treated with thrombolytic agents,
but as part of management after infarction all received low
dose subcutaneous heparin (1,000 units twice daily).
Analogous scintigraphic studies were performed in two
groups ofcontrol subjects. Control group I comprised eight
patients with manifestations of cerebrovascular disease (two
with recent cerebral infarction, six with transient ischemic
attacks) who underwent platelet scintigraphy for evaluation
of the neurologic problem. This group was used to provide
nonmatched control patients at risk for atherosclerotic coro-
nary disease, but who would be unlikely to exhibit platelet
deposition in the coronary vessels. Obviously, some of these
patients may have had, in addition to documented cerebro-
vascular lesions, occult coronary atheromatous disease, but
none had either clinical or electrocardiographic manifesta-
tions of acute ischemic cardiac disease.
Control group 2 comprised seven patients who were ad-
mitted to the cardiac intensive care unit with angina. In-
farction was excluded by electrocardiographic and enzy-
matic criteria in six of these patients. The seventh patient
underwent scintigraphy after angiographically documented
thrombolysis of an occluded coronary artery bypass graft.
Labeling of platelets. Autologous platelets were sepa-
rated by differential centrifugation from 70 ml of venous
blood anticoagulated with acid-citrate-dextrose solution
(ACD). The platelets, suspended in ACD:0.9% saline so-
lution (1:7, volume for volume, pH 6.5), were labeled by
incubation with indium-lII-8-hydroxyquinoline as de-
scribed previously (21). The indium-Ill-labeled platelets
then were washed sequentially with the ACD-saline solution
and with autologous platelet-poor plasma before being re-
suspended in platelet-poor plasma for reinjection. The ad-
ministered activity of labeled platelets was between 230 and
550JLCi (Human Study Committee approval 82-9281 , dated
April 28, 1982). Total body radiation was estimated to be
0.68 rem or less and 15.0 rem or less for the spleen (the
critical organ).
The stability of the label and platelet life span with in-
dium-labeled platelets are comparable with those of chro-
mium-51-labeled platelets (7,21). The function of labeled
platelets is well preserved (7,22,23).
Labeling of red blood cells. Red cells were labeled in
vivo by intravenous injection of 15.4 mg stannous pyro-
phosphate (Technescan PYP Mallinckrodt) reconstituted in
3 ml of sterile 0.9% saline solution, followed 30 minutes
later by injection of 2 to 6 mCi of technetium-99m
pertechnetate.
Scintigraphy. All studies in patients with suspected in-
farction or angina were performed while patients were being
monitored continuously within the cardiac care unit. In pa-
tients with infarction and in subjects in control group 2
(those with angina and without infarction), scintigrams were
obtained twice. Early images were obtained 1 to 6 hours
after administration of indium-Ill-labeled platelets. Late
images were obtained at 18 to 24 hours. The patient's red
cells were labeled with technetium-99m at the beginning of
each of these sets of data collections. Images were obtained
with a portable scintillation camera (Siemens LEM) with a
25 cm diameter, 63 mm thick sodium iodide (thallium)
crystal fitted with a medium energy (250 keY), 4000 parallel
hole collimator. A medium energy collimator was employed
to minimize the effects of septal penetration by indium-Ill
photons on the quality of the technetium-99m images.
Patients in control group J (those with neuorologic symp-
toms), underwent imaging once, 18 to 24 hours after admin-
istration of labeled platelets, an interval corresponding to
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the time of the late imaging study in the other two groups.
The images in these patients were obtained with a large field
scintillation camera (Siemens LFOY) with a 40 em diam-
eter, 127 mm thick NaI(Tl) crystal fitted with a medium
energy (300 keV), 5200 parallel hole collimator.
For the first image in each patient (generally the anterior
indium-ll J image), the spectrometers of the scintillation
camera were adjusted to include separate 20% windows
centered over both the 173 and 247 keY photopeaks of
indium-Ill. After completion of this indium image, tech-
netium-99m pertechnetate was injected for red cell labeling.
Without moving the patient or the camera, an image of this
tracer was obtained with a 20% window centered over the
140 keY photopeak of the technetium. For subsequent in-
dium images, only the 247 keY photopeak of the indium
was recorded. Paired indium and technetium images were
always obtained without intervening adjustments in patient
or camera position. All of the recorded images were digi-
tized and stored as 64 x 64 matrices on an ADAC computer.
Contributions from activity in the liver and spleen were
minimized by careful positioning of the camera and slight
cranial angulation « 10°) of the detector. No shielding of
abdominal structures was employed. Approximately 10 to
25% of the total counts in each image originated from the
heart. Images were obtained in the anterior projection in 21
of 24 patients (I patient with infarction and 2 control patients
underwent imaging only in the left anterior oblique projec-
tion). When possible, images were obtained also in the 10°
right anterior oblique and 30° left anterior oblique projec-
tions. A total of 150,000 to 600,000 counts was collected
for each tracer in each projection. This required an acqui-
sition time of 2 to 3 minutes for each technetium image and
15 to 25 minutes for each indium image. Crossdown (ac-
tivity detected in the 140 keY window of technetium-99m
attributable to scatter from the higher energy indium-Ill
photons) was measured at less than 5%; this low value was
achieved by the administration of more technetium-99m
activity (2 to 6 mCi) than indium-Ill activity (230 to 550
/LCi).
All of the paired scintigrams in the study were evaluated
for patient movement by analysis of the position of the
vascular structures in the corresponding technetium and in-
dium images. In two patients without overt coronary dis-
ease, movement between paired images was demonstrated;
these two patients were not included in the study. None of
the scintigrams in the infarction patients was excluded on
the basis of patient movement. No early scintigrams were
available for analysis in Patient 4, and no late scintigrams
were available in Patient 23 (in both owing to technical
instrument failures).
Computer processing of scintigrams. Since the in-
dium-Ill platelet scintigram alone does not distinguish be-
tween platelets incorporated into thrombi and those in cir-
culating blood, the images were corrected by subtraction of
blood pool activity by using the following method (12,18-20):
In each picture element (pixel) of the scintigram,
where InExc (indium excess) is the net indium activity re-
flecting the accumulation of labeled platelets, InTOT is the
measured total indium activity in that pixel and InBP is the
indium activity associated with labeled platelets in the cir-
culating blood pool. The value of InBP for each pixel is
determined from:
I - T ( InREF )nBP - c ,Tc
REF
where Tc is the measured technetium-99m red cell activity
in that pixel and InREP and TCREP are the indium and tech-
netium activities, respectively, measured in a reference re-
gion of high blood pool activity (for example, over a large
vessel) in which active platelet deposition is presumed to
be absent.
Reference regions. In this study, the reference regions
were chosen by assigning regions of interest on the digitized
images over the origin of the right common carotid artery
(n = 22) or over the origins of one or both pulmonary
arteries (n = 2). The latter two subjects had a recent catheter
in the region of the right common carotid, which precluded
the use of this region for reference purposes. The reference
regions were chosen to reflect vascular structures at distance
from the detector similar to that of myocardium and coronary
arteries, thereby minimizing differences in photon detection
efficiency (attenuation) attributable to different amounts of
interposed tissue. In individual subjects, different reference
regions gave similar values for the InREP/TcREP ratio. For
example, in Patient 4, the values of InREplTcREP were 0.611
over the right pulmonary artery, 0.576 over the proximal
main pulmonary artery and 0.604 over the right common
carotid artery (mean ± standard deviation 0.597 ± 0.019).
After the InREP/TcREP ratio had been determined from the
reference region in a pair of images, it was used to calculate
the value of InBP for each pixel of the indium scintigram,
which was then subtracted from the value of InTOT for each
pixel to yield an image of the distribution of InExc. For the
computer display of these InExc images, pixels where the
calculated value of InExc was negative were set to zero.
However, for quantitative analysis, the calculated values of
both InExc and percent indium excess (see later) within the
entire cardiac contour and within visually identified foci
reflect the summation of both positive and negative pixel
values.
To determine the potential effects of statistical variation
in the scintigraphic analysis, a region of interest encom-
passing the entire cardiac contour was delineated on the
technetium image of each pair. The total technetium and
indium counts within this region and within the reference
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regions were determined. These values were assessed for
comparability in patients with infarction and those in control
groups I and 2.
Analysis of scintigrams. All unsubtracted and sub-
tracted scintigrams were interpreted independently in ran-
dom order by two investigators who were blinded with re-
spect to patient identification, diagnosis and study sequence.
Each observer reviewed the images by viewing them on the
color video display of the computer. The cardiac contour
region of interest (assigned on the technetium-99m red cell
image of each pair) was superimposed on the unsubtracted
and subtracted indium images to facilitate localization of
foci of increased indium activity and InExc, respectively.
The technetium red cell images were not shown to the ob-
servers during their analysis of the indium images. The
scintigrams were judged to be positive if they demonstrated
a localized focus of increased activity (unsubtracted image)
or an identifiable focus of indium (subtracted image) within
the cardiac contour. Among the total of 38 sets of scinti-
grams, only 2 led to initial disagreements between observ-
ers . Both were resolved by consensus.
The following quantitative analyses were performed : the
mean value of InExc/pixel within the cardiac region of in-
terest was determined and the values obtained in patients
with and without infarction were compared. When a visually
identified focus was observed, a region of interest encom-
passing this focus was assigned and the mean value of
InExc/pixel within the focus was determined. This was com-
pared with that for the remainder of the cardiac region of
interest (excluding the focus) . In addition, the fraction of
total InExc within the cardiac contour within a visually iden-
tified focus was calculated. The percent of indium excess
(% IE), reflecting local platelet deposition in thrombus rel-
ative to the activity in the circulating blood in that region
was computed for the entire cardiac region of interest as:
InExc in the region% IE = x 100.
In BP in the region
This calculation assumes that the quantity of labeled red
blood cells incorporated into thrombus is small in compar-
ison with the quantity of labeled platelets incorporated. His-
tologic examinations of experimentally induced coronary
arterial thrombi in dogs support the validity of this as-
sumption (20). The % IE values were compared for infarc-
tion and control patients and for those images subjectively
interpreted as negative versus those interpreted as positive .
Statistical comparison of continuous variables between
various groups were made with Student's t test for unpaired
observations. Comparison of raw count distributions were
made by analyses of variance . Statistical comparisons of
discrete variables between various groups were made with
the continuity-corrected chi-square test.
Results
Visual Analyses
Patients with myocardial infarction. Localized foci
of indium excess were detected in the subtracted indium-
III platelet scintigrams (lnExc images) in seven of eight
patients studied at the early imaging time (I to 9 hours after
onset of infarction and as soon as possible after admission)
and in eight of nine patients studied at the later imaging
time (18 to 24 hours after onset) (Table I). The foci of
indium excess corresponded with the expected anatomic
distribution of the coronary artery supplying the region of
infarction in each of the positive studies.
Control group 1. Among the eight patients in control
group I (those with neurologic symptoms), localized indium
excess in the region of the heart was seen in only one patient
in the area of the left ventricular outflow tract (X? = 7.09,
P < 0.01) . This difference is significant when compared
with patients with infarction at the later imaging time. The
single positive result in this group may represent a false
positive finding or detection of occult coronary artery
thrombosis .
To determine whether platelet deposition in the carotid
artery reference region in the patients with neurologic symp-
toms might be causing increased values for the observed
InREF/TcREF ratio and thereby spuriously causing a decrease
in the values of InExc in the cardiac region, images were
reprocessed with a separate pulmonary artery reference re-
gion . Visual analysis of the cardiac InExc yielded results
identical to those obtained when carotid reference regions
were used. None of these reprocessed images demonstrated
indium excess in the carotid reference region . Furthermore,
seven of the eight patients had arteriography which dem-
onstrated that the carotid origins were free of disease.
Control group 2. In control group 2 (angina without
recent infarction), the subtracted scintigrams were inter-
preted as negative in all seven patients at both the early and
late imaging times (versus the patients with infarction, X~
= 8.24 and 9.14, p < 0.01 for early and late imaging
times , respectively).
False positive images. Visual analysis of the unsub-
tracted indium-III platelet scintigrams in the group of pa-
tients with infarction (early) revealed only one of the seven
foci seen on the subtracted images. Similarly, only one of
the eight foci detected at the later imaging time was seen
on unprocessed images. Apparent false positive foci of in-
creased activity were seen in one early and three late un-
subtracted images. However, these foci were not confirmed
on the InExc images and did not correspond to sites of
presumed coronary thrombosis . Similarily, apparent false
positive foci were seen on unsubtracted images in three of
eight patients in control group 1 and in two of seven patients
in control group 2. Comparison of the unsubtracted indium
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Early Scintigraphy Late Scintigraphy
Pain to Indium Indium Indium Indium
Injection Foci Excess Foci Excess
(h) (subtracted) (%) (subtracted) (%)
Patients With Infarction
3.0 + 28.6 + 24.8
8.1 + 17.4 + 23.8
4.3 + 16.3 3.1
0.5 * * + 19.0
8.7 + 15.0 + 23.4
5.0 + 14.8 + 17.4
9.0 + 50.7 +.t 6.6
2.3 + 9.2 + 10.8
7.0 -1.2 +,t 6.3
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- 1.1 ± 3.6
*No scintigram obtained; tleft ventricular thrombi identified and confirmed independently by echocardiography. Sites of myocardial damage were
determined from electrocardiographic data. A = anterior; Control Group I = patients with neurologic symptoms; Control Group 2 = patients with
angina but no infarction; Inf = inferior; Lat = lateral; + = distinct focus of indium excess present; - = no distinct focus of indium excess detected.
platelet images with the corresponding technetium red cell
images showed that these foci of apparently increased ac-
tivity were sites of increased blood pool activity.
Representative scintigrams. Figure I illustrates the
scintigrams from a patient in control group I in whom no
focus of indium excess was identified. Figure 2 shows the
images of a patient (Case 6) with an inferior wall infarction.
No focus of increased indium activity was identified on the
uncorrected image (Fig. 2a). The technetium red cell scin-
tigram (Fig. 2b) shows the distribution of blood pool activ-
ity. A distinct focus of indium excess, corresponding to the
region of the right coronary artery, is evident in the corrected
scintigram (Fig 2c). Figure 3 shows the scintigrams from
another patient (Case 2) who had extensive anterior wall
infarction. The corrected scintigram demonstrates a focus
of activity that corresponds to the distribution of the left
anterior descending coronary artery in this left anterior oblique
projection with partial cranial angulation.
Autopsy and angiographic data. One patient (Case 8)
died 4 days after the onset of infarction. Autopsy revealed
a posteroinferior infarction, ventricular rupture and peri-
cardial tamponade. Three adjacent areas of high grade ste-
nosis were identified in the right coronary artery. Each was
associated with thrombus and all were in the region cor-
responding to the focus of indium excess detected scinti-
graphically. It was not possible to obtain thrombus for counting
of indium activity in vitro. Patients 3 and 7 had subsequent
angiography that demonstrated very high grade stenosis of
the right and proximal left anterior descending coronary
arteries, respectively, in areas corresponding to the foci of
indium excess.
Echocardiographic data. In two patients, separate and
discrete foci of indium excess were detected in the region
of the left ventricular apex. Serial real time two-dimensional
echocardiograms obtained by observers blinded to the re-
sults of indium platelet scintigraphy demonstrated extensive
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Figure 1. Digitized scmngrams
obtained in the anterior projection
from a patient (Case 15) without
overtcoronarydisease. Color scale
ranges from red (peak activity in
the scintigram) to yellow, green
and blue. Ia , Total indiumactivity
including circulatingindium plate-
let activity. lb, Technetium-99m
scintigram indicating blood pool
activity. Ic , Indium platelet scin-
tigramwithbloodpoolsubtraction;
no foci of indiumaccumulation are
apparent in the region of the
myocardium.
akinesia involving the left ventricular apex and apical in-
traventricular thrombus in both regions . One patient dem-
onstrated a very high level (42%) of indium excess at the
apical focus with early scintigraphy and 8.2% at 24 hours.
This patient underwent anticoagulation with heparin . The
thrombus persisted judging from echocardiographic results .
In the second patient, no indium excess was identified in
the early scintigram. However, an 8.0% indium excess was
identified at the apex after 24 hours (at the time of echo-
cardiographic examination) .
Quantitative Analysis of Images
Indium excess. The individual values for indium excess
(% IE) in the entire cardiac region of interest for each patient
are shown in Table 1. The mean value of indium excess for
the patients with infarction was 18.9 ± 15.3% at the early
imaging time and 15.0 ± 8.5% at the later imaging time.
The corresponding early value in control group 2 was 0 .6
± 4.7% (p < 0 .005 compared with patients with infarction
imaged early) and the corresponding late value in all control
patients was 0.4 ± 4.1 % (p < 0.001 compared with patients
with infarction imaged late) . For all scintigrams with vi-
sually identified foci of net indium accumulation (n = 16),
indium excess averaged 19.1 ± 11.2% , whereas the cor-
responding mean value for negative scintigrams (n = 21)
was 0 .1 ± 3.6% (p < 0 .(01) .
Total indium and technetium activity. Individual data
in Tables 2 and 3 show total indium and technetium activity
in the cardiac and reference regions of each patient, along
with the number of pixels in each region and the InRErlTcREF
ratio . The group data for these values are summarized in
Table 4 . There are no significant differences in any of these
values among the different groups. Accordingly, it is highly
unlikely that the scintigraphic results in any of the group of
patients reflected simply a greater degree of statistical scatter
in the images from a group .
The total indium excess within the cardiac region of
interest was significantly greater for both early and late
studies in patients with infarction than in control patients
(Table 5) . In the early and late scans in patients with in-
farction , the indium excess in the visually identified foci
constituted 40.6 ± 12.2 and 42.5 ± 26.7%, respectively,
of the total indium excess in the cardiac region of interest.
Figure 2. Digitized scintigrams from a patient
(Case 4) with inferior wall infarction (color
scale as in Fig. 1). 2a, Total indium activity
with apparent focus of indium excess (center
of myocardial region). 2b, Technetium-99m
scintigram indicating blood pool activity. 2c,
Indium platelet scintigram of the myocardial
region with blood pool subtraction. 2d, Indium
platelet scintigram with blood pool subtraction
(entire field of view). Apparent focus of in-
dium excess (2a) corresponds to an area of
peak circulating activity (2b). No focus of in-
dium excess is apparent in this region after
blood pool subtraction (2c and d). A separate
focus of indium excess is apparent (arrow, 2c
and 2d) in a region corresponding to the right
coronary artery. The focus is higher on the
color scale in 2c (the myocardial contour) be-
cause each image is scaled with respect to peak
activity in that image. The focus was not ap-
parentwithoutbloodpool subtraction.The more
diffuse inferoapical area of indium activity in
the subtracted scintigram (2c and d) may rep-
resent spillover from spleen activity in this pro-
jection, and the area was not interpreted as a
focus.
Figure 3. Digitized scintigrams from a patient
(Case 2) with an extensive anterior wall infarc-
tion (color scale as in Fig. 1). 3a, Total indium
activity. 3b, Technetium-99m blood pool activ-
ity. 3c, Subtracted indium platelet activity in-
dicating a focus (arrow) that corresponds to the
distribution of the left anterior descending and
diagonal branches of the left coronary artery in
this left anterior oblique projection with partial
cranial angulation.
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Table 2. Isotope Count Data in Myocardial and Reference Regions in Nine Patients With Infarction
Pixels In-III Tc-99m Pixels Tc-99m In-III/Tc-99m % IE
Case Scintigraphy (heart) (heart) (heart) (ref. region) (ref. region) (ref. region) (heart)
Early 528 25,322 35,530 54 4,048 0.544 28.6
Late 548 53,224 71,094 31 5,338 0.600 24.8
2 Early 620 25,946 28,702 57 2,947 0.770 17.4
Late 218 42,486 50,408 51 3,365 0.681 23.8
3 Early 447 48,129 68,057 40 5,304 0.608 16.3
Late 713 64,560 84,064 61 5,137 0.745 3.1
4 Late 585 124,231 174,862 41 10,566 0.605 19.0
5 Early 226 76,412 122,805 41 14,689 0.541 15.0
Late 215 49,287 84,297 37 16,301 0.474 23.4
6 Early 405 145,380 174,245 43 17,248 0.727 14.8
Late 277 95,878 106,186 59 18,567 0.769 17.4
7 Early 348 102,930 180,207 39 15,336 0.379 50.7
Late 276 123,795 211,831 32 7,082 0.548 6.6
8 Early 516 73,284 87,494 44 6,752 0.767 9,2
Late 449 67,923 80,787 53 8,087 0.759 10.8
9 Early 487 131,508 167,624 46 13,238 0.794 -1.2
Late 797 248,529 288,257 100 24,199 0,811 6,3
Mean ± SO 450 ± 169 49 ± 15 16.8 ± 11.6
Early scintigraphy = I to6 hours after the injection of labeled platelets; late scintigraphy = 18 to 24hours after the injection of labeled platelets;
pixels (heart), pixels (ref. region) = number of pixels within myocardial contour or reference region, respectively; In-III (heart), Tc-99m (heart),
Tc-99m (ref. region) = number ofcounts for each isotope in the cardiac contour or reference region, respectively; In-llllTc-99m = ratio of In/ III to
Tc-99m in reference region (mean value); % IE (heart) = indium excess for myocardial region (see text). Values at the bottom of the pixel and % IE
column represent the mean ± standard deviation.
The corresponding fraction of total indium excess in the
focus was 86% in the single control group 1 subject with a
positive scintigram.
Also shown in Table 5 are the values for indium excess
per pixel (lnExc/pixel) in visually identified foci and in the
remainder of the cardiac region of interest. The values in
the visually identified foci for patients with infarction are
approximately twice those in the remainder of the cardiac
region and greatly exceed those in the cardiac region for
the control subjects.
Discussion
Detection of coronary thrombi. Our results suggest that
coronary thrombi are detectable in patients evaluated with
a procedure employing indium-labeled platelets and tech-
netium-labeled red cells and a subtraction technique. We
recently reported validation of this method in experimental
animals (19) as well as the detection of coronary thrombi
(20) and the noninvasive assessment of the efficacy of coro-
nary thrombolysis (20). Other investigators (10) have de-
tected coronary thrombi in experimental animals by indium-
111 platelet scintigraphy without blood pool subtraction after
thrombosis had been induced with electrical current pro-
ducing endothelial injury. However, indium platelet scin-
tigrams without blood pool subtraction are not adequately
sensitive for detection of small coronary thrombi, whereas
such thrombi are demonstrable when the subtraction method
is employed (20). Recent experimental studies (19) dem-
onstrated the quantitative accuracy of the indium-
IllItechetium-99m dual isotope technique by showing a
close linear correlation (r = 0.89, P < 0.005) between
scintigraphically determined indium excess and in vitro
thrombus to blood ratios.
In the present study, coronary thrombi were detected in
seven of eight patients studied within 9 hours of the onset
of infarction and in eight of nine imaged at later intervals
(18 to 24 hours after the onset of infarction). In one patient
studied early after onset of infarction, three patients studied
late after the onset of infarction and three patients without
overt cardiac disease, false positive results would have been
obtained without the use of the subtraction technique. False
positive foci of apparent platelet deposition in uncorrected
images corresponded to areas of peak blood pool activity,
but not to foci of true indium excess in the subtracted images.
Myocardial infarction versus coronary thrombus. It
is unlikely, at least within the first 24 hours, that the focal
uptake seen in the present study was due primarily to uptake
of platelets into tissue undergoing infarction. In our earlier
animal studies (20), experimental coronary thrombi were
detected with the subtraction technique and the foci of in-
dium excess were no longer apparent after documented coro-
nary thrombolysis. In contrast to thrombi, myocardium
undergoing infarction did not accumulate sufficient platelets
to be detected scintigraphically. Riba et al. (10) studied
myocardial indium-Ill platelet accumulation 2 to 24 hours
after the induction of coronary thrombosis in dogs and dem-
onstrated thrombus to blood activity ratios of 52 ± 12:I.
Infarcted myocardium did not concentrate indium platelets
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Table 3. Isotope Count Data in Myocardial and Reference Regions in Patients Without Infarction
Pixels In-I I I Tc-99m Pixels Tc-99m In- I IIlTc-99m % IE
Case Scintigraphy (heart) (heart) (heart) (ref. region) (ref. region) (ref. region) (heart)
Group I'
10 346 91.891 166.063 18 4.771 0.794 -0.3
II 306 69.371 58.441 44 5.125 1.168 1.6
12 265 56.157 56.812 62 9,031 0.999 -1.1
13 234 72,448 79,417 41 7.392 0.940 -3.0
14 185 55,992 61.825 21 5.802 0.827 9.4
15 155 22.645 78.598 23 11.506 0.274 5.0
16 216 12.731 90.346 29 10.219 0.141 -0.1
17 310 92.763 105.628 72 26,646 0.861 2.1
Mean ± SO 252 ± 66 39 ± 20 1.7 ± 3.9
Group 2t
18 Early 462 176.883 234,482 63 14.931 0.781 -3.4
Late 371 109.529 165.227 33 16,489 0.718 -7.7
19 Early 378 139.840 201.301 74 17.041 0.700 -0.8
Late 339 124,487 168.750 65 22.963 0.758 -2.7
20 Early 196 67.842 80.943 99 24.965 0.787 +6.5
Late 318 92.180 118.834 39 7.432 0.763 + 1.7
21 Early 326 114.802 132.697 92 29,548 0.832 +4.0
Late 379 108.920 127,789 139 31.872 0.840 +1.5
22 Early 350 115.032 149.181 54 17.585 0.740 +4.2
Late 338 123,879 168,373 61 17,688 0.734 +0.2
23 Early 332 93,745 144,746 32 7.631 0.614 +0.5
24 Early 470 147.712 237.116 61 16,772 0.670 -7.0
Late 632 161,434 217,456 III 21.358 0.740 +0.3
Mean ± SO Early 359 ± 93 68 ± 23 0.6 ± 4.7
Late 396 ± 117 75 ± 41 - 1.1 ± 3.6
'Group I = patients with neurologic symptoms. tGroup 2 = patients with angina but no infarction. Other abbreviations as in Table 2.
dium. In addition, in dogs with coronary occlusion for 24
hours, Romson et al. (24) found that in vitro indium-Ill
tissue to blood activity ratios were less than 4: I in zones of
diminished flow.
Ventricular thrombi. Ventricular cavitary thrombi have
been detected without vascular pool subtraction (17) with
imaging performed 48 to 96 hours after injection of indium-
III platelets. However, later imaging allows greater time
for the incorporation of platelets into thrombus and for re-
duction of circulating indium platelet activity. Ventricular
thrombi were detected in two patients in the present study
in scintigrams performed 24 hours after the injection of
labeled platelets. Thus, the ventricular thrombi (at the site
of the recent infarction) were detected earlier than has been
the case in studies without vascular pool subtraction (17).
Rate of platelet incorporation into coronary
thrombi. The rate of incorporation of platelets into venous
thrombi decreases with the age of the thrombus (25). The
rate of platelet accumulation in thrombi also may depend
on several other factors including blood coagulability, levels
of humoral agents, local stasis and vasospasm. Furthermore,
the work of Riba et al. (10) indicates that experimental
canine coronary thrombi can be detected scintigraphically
(without vascular subtraction), if platelets are injected within
I hour of occlusion but not when injected 22 hours after
occlusion. These data indicate that the rate of incorporation
of platelets into coronary thrombi may be slower with older
thrombi. To be useful for assessment of potentially salutary
interventions, the clinical detection of thrombus is needed
early after the onset of threatened or evolving infarction.
For these reasons, subtraction of circulating indium platelet
activity seems particularly suitable for earlier detection of
coronary thrombi and for serial application in studies de-
signed to characterize the role of platelets in the pathogenesis
of acute myocardial infarction.
Mass of coronary thrombus and extent of infarc-
tion. Localized foci of true indium excess correspond with
the anatomic site of coronary thrombosis in experimental
animals (20). However, their magnitude depends on the
mass and surface area of the thrombus, its age and the
duration of exposure of labeled platelets to the thrombus.
The mass of a coronary thrombus is not necessarily related
directly to the extent of infarction. Thrombus may extend
both proximally and distally from the site of occlusion in
small or large vessels. Fresh thrombus comprises a variable
fraction of total occlusive thrombus in patients with an ath-
eromatous plaque, but it often constitutes a major compo-
nent. As indicated by angiography in one of our patients
(Case 3) with a high degree of residual atheromatous ob-
struction in the vessels supplying the ischemic zone, the
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Table 4. Quantitative Analysis (indium and technetium count distributions)
Group 1* Group 2t
MI MI NoMI NoMI NoMI
Early Scans Late Scans Late Scans Early Scans Late Scans
Counts (n = 8) (n = 9) (n = 8) (n = 7) (n = 6)
Cardiac ROI
Total Tc-99m 107,319 ± 63,173 127,976 ± 79,616 80,271 ± 22,796 168,638 ± 57,768 161,072 ± 35,215
Tc-99mJpixel 284 ± 200 318 ± 199 337 ± 98 461 ± 52 416 ± 74
Total In-III 71 ,685 ± 46,682 96,651 ± 64,699 60,028 ± 29,639 122,265 ± 36,108 120,072 ± 23,487
In-Ill/pixel 200 ± 130 230 ± 119 236 ± 91 339 ± 34 310 ± 46
Reference ROI
Total TC 9,945 ± 5,747 10,960 ± 7,144 10,062 ± 7,130 18,353 ± 7,071 19,634 ± 8,079
Total In 6,216 ± 3,836 7,484 ± 5,791 7,260 ± 6,757 14,133 ± 6,462 14,992 ± 6,834
InffC 0.64 ± 0.15 0.67 ± 0.12 0.78 ± 0040 0.73 ± 0.08 0.76 ± 0.04
*Group I = patients with neurologic symptoms. tGroup 2 = patients with angina but no infarction. MI = myocardial infarction; ROI = region
of interest; other abbreviations as in Table 2. Values indicate the mean ± standard deviation.
clot may contribute an anatomically minor but hemodynam-
ically major fraction of the obstruction. Clearly, athero-
sclerotic plaques may not accumulate platelets at a rate
sufficient to be detected scintigraphically. Interpretations of
the significance and absolute magnitude of indium excess
should be made in the context of these considerations.
Comparison of patients with control group. Quantitative
analysis of indium excess (Table 5) indicates substantially
higher levels of indium excess (% IE) and indium excess
counts/pixel in the scintigrams from patients with infarction
compared with those from patients without documented
coronary disease (% IE 19.1 ± 11.2% for those with vi-
sually identified foci and 0.4 ± 4.3% for control subjects).
Quantitative analysis of indium and technetium count dis-
Table 5. Quantitative Analysis (indium excess)
tributions (Table 4) demonstrates no significant differences
between infarction and control groups for unsubtracted in-
dium counts/pixel and technetium counts/pixel in either the
myocardial or reference regions. The observed differences
in indium excess between infarction and control groups are,
therefore, not due to differences in raw count distribution,
counts per pixel or statistical noise.
Possible limitations. The visually delineated foci ac-
counted for 40 to 43% of total myocardial indium excess.
The remainder may represent platelet accumulation outside
the visually defined focus (in endothelium or in fragments
of embolized clot) and, although unlikely, significant plate-
let accumulation in infarct zones cannot be excluded. In
addition, some spillover of the detection of gamma activity
Group 1* Group 2t
MI MI No MI NoMI No MI
Early Scans Late Scans Late Scans Early Scans Late Scans
(n = 8) (n = 9) (n = 8) (n = 7) (n = 6)
Total heart
InExc (counts) 10,178 ± 11,580 10,228 ± 4,960 872 ± 2,152 681 ± 6,050 -1,439 ± 4,178
%IE 18.9 ± 15.3 15.0 ± 8.5 1.7 ± 3.9 0.6 ± 4.7 -1.1 ± 3.6
% of InExc 40.6 ± 12.2 42.5 ± 26.7 § :j: :j:
In focus
% cardiac 26.6 ± 804 23.0 ± 13.3 § :j: :j:
pixels in focus
InExc (counts/pixel)
Focus 5204 ± 39.9 41.9 ± 20.7 § :j: :j:
Remainder of 24.7 ± 30.8 20.2 ± 13.3 2.0 ± 6.2 104 ± 16.0 - 4.0 ± 11.3
cardiac ROI
*Group I = patients with neurologic symptoms. tGroup 2 = patients with angina but no infarction. :j:Nofocus identified. §Among the eight patients
in this group, only one exhibited a visually identified focus of indium excess. In this patient, the focus contained 57 counts/pixel, accounting for 86%
of the total indium excess. As noted in the text, this focus may have reflected an occult coronary lesion or a false positive result. Numeric data were
calculated for indium excess in the entire heart and for the proportion of the calculated indium excess in the visually identified focus. The indium excess
(counts/pixel) in the focus and the remainder of the heart are provided for each group. Inexc (counts) = total indium - indium blood pool (InBP);
% IE = InExclOO; ROI = region of interest; other abbreviations as before.
InBP
JACC Vol. 4, No.5
November 1984:975-86
FOX ET AL.
SCINTIGRAPHIC DETECTION OF CORONARY THROMBI
985
would be anticipated from the defined focus to surrounding
myocardium.
Scintigraphy of the heart and coronary vessels is, of
course, formidable because of potential movement artifact
and complex geometric and physical considerations that in-
fluence attenuation and resolution. In this study, indium
excess was calculated pixel by pixel and the percent of
indium excess reflects net indium activity for the entire
myocardial region of interest. Regions with similar blood
pool activity can be compared within each scintigram in this
fashion, but comparison between scintigrams are clearly
influenced by constraints related to projection and must,
therefore, be interpreted in the light of these considerations.
Validation of findings. Independent validation of the
presence of coronary thrombi is possible directly from au-
topsy information (when available) or indirectly from an-
giographic data. Autopsy information was obtained in one
patient and angiographic data in three. Coronary angiog-
raphy is not generally performed in the context of acute
infarction at our institution and was not considered justifiable
for the purposes of this study alone. Angiographic infor-
mation was available for one patient who underwent suc-
cessful coronary graft thrombolysis and for two patients
studied during the recovery phase after infarction. In ex-
tensive studies in animals (19), the dual tracer technique
was validated and demonstrated accurate localization of
coronary thrombi (20). Thrombi were detected with a high
degree of sensitivity (clots as small as 12 mg were detected).
These data support the specificity of the technique and are
consistent with a close relation of scintigraphic results and
results of tissue analysis in vitro. In the present study the
frequency of coronary thrombi is comparable with that found
in angiographic studies by others (1-5) demonstrating a high
frequency of coronary thrombus early in the course of acute
myocardial infarction.
Location of coronary thrombus and site of infarc-
tion. The locus of myocardial infarction in the present study
was determined by electrocardiographic criteria. The vessel
presumed to supply the infarct zone, as assessed from these
data, was compared with the site of indium excess recog-
nized scintigraphically (Table 1). The area of increased in-
dium activity in all cases corresponded to the expected lo-
cation of the thrombosed coronary vessel. Indium-Ill-labeled
platelets have been shown in studies with animals (26) to
accumulate in zones of reperfusion and have been detected
scintigraphically . However, in the present study, it is un-
likely that the distinct foci of indium excess reflected such
zones of reperfusion. Although spontaneous reperfusion oc-
curs, it is rare within the first 24 hours after infarction.
None of the patients with infarction received thrombolytic
agents (one patient in control group 2 underwent scintig-
raphy after successful thrombolysis). Myocardial enzyme
plasma time-activity curves were obtained for all patients
and did not suggest acceleratedwashout typical of reperfusion.
Clinical application. The method developed is poten-
tially applicable to the detection of coronary thrombus, as-
sessment of the efficacy of thrombolysis and sequential eval-
uation of the fate of the vessel in which thrombolysis has
occurred. With the temporal dependence of myocardial sal-
vage (27) and the prospect of availability of intravenously
active thrombolytic agents that do not induce depletion of
fibrinogen (28), a noninvasive method for detection and
serial assessment of coronary thrombosis may be particu-
larly useful. The method we have described provides a po-
tential means for assessing the influence of antiplatelet ther-
apy on the rate of incorporation of platelets into thrombi
and for sequentially evaluating the fate of thrombi detected.
In addition, it may be useful in studies designed to char-
acterize the role of platelets in acute coronary artery disease
manifest not only by infarction, but also by crescendo angina
or symptoms due to coronary vasospasm.
We thank Julio Perez, MD for the echocardiographic studies, Kevin Hop-
kins and Jackie Wilson for their technical assistance and Barbara Donnelly
for preparation of the manuscript.
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